These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34098288)

  • 1. Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees.
    Hoffman LA; Vilsaint CL; Kelly JF
    J Subst Abuse Treat; 2021 Dec; 131():108464. PubMed ID: 34098288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes toward opioid use disorder medications: Results from a U.S. national study of individuals who resolved a substance use problem.
    Bergman BG; Ashford RD; Kelly JF
    Exp Clin Psychopharmacol; 2020 Aug; 28(4):449-461. PubMed ID: 31556675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.
    Andraka-Christou B; Nguyen T; Harris S; Madeira J; Totaram R; Randall-Kosich O; Atkins D; Ford J
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):589-603. PubMed ID: 32543922
    [No Abstract]   [Full Text] [Related]  

  • 4. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.
    Andraka-Christou B; Atkins D
    Am J Drug Alcohol Abuse; 2020 Nov; 46(6):749-760. PubMed ID: 32969757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes and beliefs among Georgia addiction treatment staff about medication for opioid use disorder in adolescents, young adults, and adults: a multi-mixed methods study.
    Welsh JW; Mataczynski MJ; Passetti LL; Hunter BD; Godley MD
    Am J Drug Alcohol Abuse; 2022 May; 48(3):347-355. PubMed ID: 35416739
    [No Abstract]   [Full Text] [Related]  

  • 6. Attitudes toward Medication for Opioid Use Disorder among Substance Use Treatment Providers.
    Pasman E; Lee G; Kollin R; Rodriguez B; Agius E; Madden EF; Resko SM
    Subst Use Misuse; 2022; 57(12):1828-1836. PubMed ID: 36041008
    [No Abstract]   [Full Text] [Related]  

  • 7. Diffusion of medications for opioid use disorder treatment in jail settings: a convergent mixed methods study of jail staff perspectives.
    Michener PS; Evans EA; Ferguson WJ; Friedmann PD
    Addict Sci Clin Pract; 2024 Feb; 19(1):10. PubMed ID: 38347634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health professionals' attitudes toward medications for opioid use disorder.
    Brown AR
    Subst Abus; 2022; 43(1):598-614. PubMed ID: 34520703
    [No Abstract]   [Full Text] [Related]  

  • 9. Attitudes Toward Medication for Opioid Use Disorder Among Pregnant and Postpartum Women and People Seeking Treatment.
    Banks DE; Fentem A; Li X; Paschke M; Filiatreau L; Woolfolk C; Cavazos-Rehg P
    J Addict Med; 2023 May-Jun 01; 17(3):356-359. PubMed ID: 37267191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder.
    Randall-Kosich O; Andraka-Christou B; Totaram R; Alamo J; Nadig M
    J Addict Med; 2020; 14(4):e44-e52. PubMed ID: 31651562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review.
    Madden EF; Prevedel S; Light T; Sulzer SH
    Subst Use Misuse; 2021; 56(14):2181-2201. PubMed ID: 34538213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
    Hughto JMW; Tapper A; Rapisarda SS; Stopka TJ; Palacios WR; Case P; Silcox J; Moyo P; Green TC
    Subst Abuse Treat Prev Policy; 2023 May; 18(1):30. PubMed ID: 37217975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.
    Huhn AS; Hobelmann JG; Strickland JC; Oyler GA; Bergeria CL; Umbricht A; Dunn KE
    JAMA Netw Open; 2020 Feb; 3(2):e1920843. PubMed ID: 32031650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail.
    Bailey A; Senthilkumar R; Evans EA
    J Addict Med; 2023 Sep-Oct 01; 17(5):568-573. PubMed ID: 37788611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community.
    Biondi BE; Vander Wyk B; Schlossberg EF; Shaw A; Springer SA
    Addict Sci Clin Pract; 2022 Mar; 17(1):15. PubMed ID: 35255967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the question of financial incentives for training amongst non-adopters of MOUD in rural primary care.
    Haggerty T; Turiano NA; Turner T; Dekeseredy P; Sedney CL
    Addict Sci Clin Pract; 2022 Dec; 17(1):72. PubMed ID: 36517926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data.
    Zhang P; Tossone K; Ashmead R; Bickert T; Bailey E; Doogan NJ; Mack A; Schmidt S; Bonny AE
    J Subst Abuse Treat; 2022 May; 136():108686. PubMed ID: 34953637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes Regarding Medications for Opioid Use Disorder Among Peer Recovery Coaches.
    Suzuki J; Loguidice F; Martin B
    J Addict Med; 2023 Jan-Feb 01; 17(1):101-103. PubMed ID: 35914085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs.
    Winograd RP; Wood CA; Stringfellow EJ; Presnall N; Duello A; Horn P; Rudder T
    J Subst Abuse Treat; 2020 Jan; 108():55-64. PubMed ID: 31277891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to Medications for Opioid Use Disorder and Associated Factors Among Adolescents and Young Adults: A Systematic Review.
    Pilarinos A; Bromberg DJ; Karamouzian M
    JAMA Pediatr; 2022 Mar; 176(3):304-311. PubMed ID: 34870707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.